Clinical trials
Withdrawn Phase 3 trials in Belgium
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2007 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 2 |
| 2014 | 3 |
| 2015 | 1 |
| 2017 | 2 |
| 2019 | 1 |
| 2024 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 16 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University Hospital, Ghent | 3 |
| Celgene | 2 |
| Bristol-Myers Squibb | 1 |
| Centocor, Inc. | 1 |
| Eli Lilly and Company | 1 |
| Institut National de la Santé Et de la Recherche Médicale, France | 1 |
| Jules Bordet Institute | 1 |
| Juno Therapeutics, Inc., a Bristol-Myers Squibb Company | 1 |
| Marinus Pharmaceuticals | 1 |
| Novartis Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Myeloma | 2 |
| Recurrence | 2 |
| Acute Kidney Injury | 1 |
| Adenocarcinoma of Lung | 1 |
| Attention Deficit Disorder with Hyperactivity | 1 |
| Bronchopulmonary Dysplasia | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Critical Illness | 1 |
| Crohn Disease | 1 |
| Giant Cell Arteritis | 1 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.